Companies / Aurinia Pharmaceuticals Inc. / Activity
Activity — Aurinia Pharmaceuticals Inc.
11 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Tang Kevin CEO | Buy | Common Shares | $5.25M | +344K +2.75% | 12,838,002 9.65% of shares | high |
| Feb 27, 2026 | Tang Kevin CEO | Buy | Common Shares | $4.17M | +300K +2.65% | 11,629,500 8.74% of shares | high |
| May 29, 2026 | Tang Kevin CEO | Buy | Common Shares | $4.02M | +263K +2.15% | 12,494,481 9.39% of shares | high |
| Jun 2, 2026 | Tang Kevin CEO | Buy | Common Shares | $3.15M | +206K +1.60% | 13,044,106 9.80% of shares | high |
| Feb 27, 2026 | Tang Kevin CEO | Buy | Common Shares | $3.03M | +215K +1.85% | 11,844,339 8.90% of shares | high |
| Mar 3, 2026 | Tang Kevin CEO | Buy | Common Shares | $2.62M | +184K +1.53% | 12,229,500 9.19% of shares | high |
| Mar 2, 2026 | Tang Kevin CEO | Buy | Common Shares | $1.65M | +116K +0.97% | 12,045,292 9.05% of shares | high |
| Mar 2, 2026 | Tang Kevin CEO | Buy | Common Shares | $1.20M | +84K +0.71% | 11,929,500 8.97% of shares | high |
| May 29, 2026 | Tang Kevin CEO | Buy | Common Shares | $35.3K | +2K +0.02% | 12,231,799 9.19% of shares | low |
| Feb 27, 2026 | Tang Kevin CEO | Buy | Common Shares | $23.0K | +2K +0.01% | 11,845,939 8.90% of shares | low |
| Jun 1, 2026 | Tang Kevin CEO | Buy | Common Shares | $1.5K | +99 +<0.01% | 12,838,101 9.65% of shares | low |